Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy Share Post Post navigation Previous PostPulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart DiseaseNext Post WYF Brings Together 400+ Students for Future Liberal Arts Leadership Summit in Macao